A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)
A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (CIU)
Sponsor: Organon and Co
Terminated
Study could not be re-supplied with study medication in a timely manner.
Other terminated trials from Organon and Co
- Contraception · Phase PHASE3 · Oct 2016
- Contraception · Phase PHASE3 · Sep 2016
- Dysmenorrhea · Phase PHASE3 · Sep 2016
- Moderate to Severe Primary Dysmenorrhea · Phase PHASE3 · Sep 2016
- Contraception · Phase PHASE3 · Feb 2014
More terminations from Organon and Co
Listed as NCT00751166, this PHASE4 trial focuses on Urticaria and remains terminated or withdrawn. Sponsored by Organon and Co, it has been updated 8 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Mar 2022 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 3 earlier versions
-
Apr 2017 — Jun 2018 [monthly]
Terminated PHASE4
-
Feb 2017 — Apr 2017 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Mar 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Organon and Co
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.